Section A. Incidence of reported ESRD. Vol 3 esrd. pg 429. A tables

Section A Incidence of reported ESRD Vol 3 esrd pg 429

Table A.1 431 Incident counts of reported ESRD: all patients by age, gender, race, ethnicity, & primary diagnosis Table A.2 433 Incident rates of reported ESRD per million population, by age, gender, race, ethnicity, & primary diagnosis Table A.3 43 Incident rates of reported diabetic ESRD per million population, by age, gender, race, & ethnicity Table A.4 437 Incident counts of reported ESRD patients, 200 2007 combined by age & primary diagnosis Table A. 438 Incident rates of reported ESRD, 200 2007 combined per million population, by age & primary diagnosis Table A.6 439 Mean age at start of ESRD therapy by age, gender, race, ethnicity, primary diagnosis, & location Table A.7 440 Incidence of reported ESRD, by primary diagnosis, 2003 2007 combined by detailed primary diagnosis Table A.8 444 Incident counts of reported ESRD patients, by diabetic status & state/territory Table A.9 447 Incident rates of reported ESRD, by diabetic status & state, adjusted per million population Table A.10 40 Incident counts of reported ESRD patients, by diabetic status & ESRD network Table A.11 41 Incident rates of reported ESRD, by diabetic status & ESRD network, adjusted per million population Throughout this reference section The incident cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule. The age of the incident patient is determined as of the date of ESRD initiation. Adjusted rates use the 200 ESRD cohort as reference (represented by outlined columns in tables). pg 430 The following symbols are used throughout this reference section CMS began collecting Hispanic ethnicity data in April 199; cells for years prior to 1996 have therefore been left blank. * Values for cells with ten or fewer patients are suppressed.. Zero values in this cell. Data for some early years are omitted from the printed tables; complete data are available on our website, at www.usrds.org.

Table A.1 Incident counts of reported ESRD: all patients by by age, age, gender, gender, race, race, ethnicity, & primary primary diagnosis 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 0-4 47 140 148 166 194 203 180 198 232 210 203 237-9 96 103 12 147 14 11 182 148 149 146 128 130 10-14 180 214 246 283 307 309 338 337 322 336 297 311 1-19 433 441 41 69 7 83 84 623 647 624 672 626 20-29 1,36 2,08 2,63 2,693 2,709 2,709 2,81 2,48 2,636 2,736 2,79 2,834 30-39 2,220 3,306 4,88,749,823,74,797,734,799,898 6,017,889 40-49 2,441 3,689 6,276 8,98 10,989 11,09 11,327 11,627 11,942 12,116 12,640 12,329 0-9 3,70,00 8,39 11,9 16,880 17,769 18,222 19,160 19,80 20,668 21,90 22,014 60-64 2,133 3,90 6,138 8,003 10,078 10,478 10,84 11,267 11,64 11,940 12,418 12,949 6-69 2,183 3,928 7,244 9,313 11,02 11,878 11,803 12,171 12,310 12,228 12,711 12,78 70-79 2,26,78 10,874 16,83 23,961 24,841 24,939 24,949 24,938 2,067 2,3 24,889 80-84 331 1,02 2,397 4,19 7,4 7,770 8,749 8,910 9,20 9,738 9,861 9,882 8+ 102 360 962 1,78 3,900 4,288 4,684,00,240,23,814 6,124 Unknown. * * * * * * * * * * * 0-19 76 898 1,087 1,16 1,230 1,246 1,284 1,306 1,30 1,316 1,300 1,304 20-44 4,869 7,131 10,637 12,37 13,269 13,171 13,120 13,134 13,401 13,742 13,99 13,831 4-64 7,211 11,399 17,66 24,848 33,210 34,98 3,391 37,202 38,471 39,616 41,789 42,184 6-74 3,790 7,411 13,09 18,686 23,890 24,764 24,10 24,622 24,871 24,770 2,33 2,446 7+ 1,32 3,687 7,968 13,14 22,928 24,013 2,66 26,413 26,867 27,786 28,388 28,234 Unknown. * * *.... *. * * Male 10,026 16,60 27,303 37,13 0,96 2,96 4,321,62 7,973 9,0 62,024 62,239 Female 7,91 13,971 23,6 33,22 43,929 4,196 4,649 47,04 46,989 47,677 48,983 48,78 Unknown * *. * *.. *. * * * White 12,64 20,792 33,820 44,68 61,809 63,919 6,00 66,410 68,469 70,134 73,141 72,668 African American 4,867 8,722 14,99 21,618 26,763 27,80 28,696 29,78 29,383 30,471 31,446 31,61 Native American 12 307 602 88 1,201 1,17 1,147 1,13 1,204 1,222 1,22 1,24 Asian 109 601 1,29 2,290 3,247 3,440 3,98 3,70 3,887 4,136 4,778,106 Other/unknown 313 111 147 942 1,07 1,43 1,24 1,804 2,019 1,267 418 411 Hispanic 12,4 11,793 12,28 13,32 13,692 13,88 14,784 1,07 Non-Hispanic 81,982 8,999 87,442 89,32 91,270 93,34 96,224 9,943 Diabetes 2,689 8,703 18,10 29,326 42,427 44,140 44,447 4,644 46,71 47,389 49,340 48,871 Hypertension 3,161 8,260 1,386 18,826 2,061 26,299 27,273 28,2 28,69 29,004 29,773 30,67 Glomerulonephritis 2,800,108 7,082 8,307 8,681 8,628 8,733 8,439 8,600 8,193 8,004 7,71 Cystic kidney 772 1,226 1,80 1,932 2,190 2,268 2,20 2,304 2,340 2,21 2,69 2,633 Other urologic 476 1,178 1,310 2,00 2,740 2,773 2,933 2,820 2,877 2,173 1,674 1,4 Other cause 1,828 3,4 4,860 7,139 9,119 9,327 9,948 10,202 10,82 12,364 13,787 14,141 Unknown cause 1,600 1,2 1,933 2,494 3,791 4,026 3,972 4,074 4,138 4,677 4,846 4,63 Missing disease 4,62 92 8 319 18 331 414 642 74 909 92 938 U.S. 17,611 29,948 49,864 69,382 93,21 96,424 98,27 101,003 103,219 10,496 109,133 109,109 U.S territories * 31 61 103 136 14 171 169 172 171 203 209 Puerto Rico 239 391 611 837 1,103 1,174 1,213 1,289 1,294 1,237 1,332 1,30 Foreign * 20 41 33 39 27 34 29 19 22 29 13 Unknown 110 143 282 38 34 22 2 187 28 304 311 319 All 17,978 30,33 0,89 70,393 94,27 97,792 99,970 102,677 104,962 107,230 111,008 111,000 Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD on our website & cd Incident counts of reported ESRD, by primary diagnosis, (A.1.1-4), patients residing in Puerto Rico & U.S. territories (A.a). Percent decrease in incident counts of ESRD patients, after dropping patients with other & unknwon race (A.b). Vol 3 esrd pg 431

Table A.1 (continued) Incident counts of reported ESRD: patients: all patients: U.S. U.S. only, only, with with unknowns unknowns dropped dropped by by age, age, gender, gender, race, race, ethnicity, & primary primary diagnosis 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 0-4 46 133 142 19 187 184 164 18 208 196 194 223-9 91 101 146 14 10 143 17 134 136 13 120 119 10-14 174 206 239 268 294 297 326 311 292 314 279 296 1-19 42 429 22 0 42 9 47 81 606 90 647 607 20-29 1,483 2,031 2,64 2,621 2,73 2,91 2,431 2,400 2,463 2,96 2,682 2,78 30-39 2,14 3,231 4,79,618,640,4,98,467,493,736,888,741 40-49 2,39 3,91 6,086 8,736 10,664 10,773 10,980 11,223 11,481 11,76 12,31 12,071 0-9 3,619,36 8,107 11,66 16,310 17,181 17,62 18,48 19,132 20,071 21,492 21,24 60-64 2,044 3,89,986 7,780 9,731 10,160 10,22 10,86 11,236 11,63 12,146 12,649 6-69 2,112 3,87 7,12 9,072 11,202 11,7 11,49 11,820 11,97 11,929 12,473 12,38 70-79 2,416,701 10,736 16,330 23,30 24,374 24,478 24,426 24,4 24,642 2,19 24,03 80-84 321 1,012 2,370 4,098 7,33 7,673 8,630 8,769 9,111 9,60 9,747 9,793 8+ 100 31 949 1,78 3,860 4,242 4,622 4,929,168,467,73 6,069 0-19 736 869 1,049 1,122 1,173 1,183 1,212 1,211 1,242 1,23 1,240 1,24 20-44 4,701 6,94 10,348 12,230 12,802 12,724 12,626 12,4 12,720 13,289 13,671 13,04 4-64 6,949 11,123 17,14 24,091 32,116 33,26 34,287 3,89 37,08 38,14 40,888 41,239 6-74 3,644 7,290 13,338 18,303 23,33 24,204 23,93 23,981 24,278 24,233 2,110 24,986 7+ 1,30 3,631 7,869 12,9 22,610 23,660 2,290 2,963 26,431 27,410 28,08 27,917 Male 9,68 16,177 26,670 36,167 49,148 1,09 2,760 3,827 6,114 8,07 60,82 61,001 Female 7,677 13,681 23,088 32,34 42,888 44,202 44,90 4,741 4,642 46,624 48,142 47,890 White 12,293 20,369 33,134 44,09 61,033 63,112 64,187 6,39 67,8 69,146 71,961 71,43 African American 4,814 8,614 14,829 21,09 26,660 27,679 28,47 29,428 29,239 30,306 31,220 31,37 Native American 124 304 99 884 1,201 1,17 1,147 1,133 1,204 1,218 1,203 1,23 Asian 104 71 1,196 2,213 3,142 3,331 3,469 3,612 3,7 4,011 4,83 4,846 Hispanic 10,721 9,918 10,43 11,093 11,478 12,132 13,418 13,678 Non-Hispanic 81,31 8,379 86,807 88,47 90,278 92,49 9,49 9,213 Diabetes 2,90 8,10 17,707 28,49 41,097 42,747 43,00 44,034 4,126 46,120 48,284 47,778 Hypertension 3,093 8,137 1,19 18,24 24,669 2,874 26,833 27,998 28,162 28,612 29,33 30,402 Glomerulonephritis 2,724 4,993 6,909 8,122 8,42 8,384 8,462 8,160 8,29 8,003 7,871 7,436 Cystic Kidney 77 1,20 1,1 1,900 2,13 2,21 2,197 2,248 2,282 2,477 2,629 2,601 Other urologic 460 1,10 1,261 1,983 2,671 2,71 2,867 2,76 2,819 2,124 1,638 1,19 Other cause 1,783 3,03 4,796 7,01 8,910 9,149 9,740 9,988 10,618 12,17 13,63 13,993 Unknown cause 1,13 1,489 1,863 2,420 3,678 3,916 3,880 3,934 3,997 4,612 4,809 4,600 Missing disease 4,41 871 476 278 41 297 366 441 47 8 68 62 All 17,33 29,88 49,78 68,701 92,036 9,297 97,30 99,68 101,76 104,681 108,967 108,891 Patients dropped 643 67 1,101 1,692 2,491 2,49 2,620 3,109 3,206 2,49 2,041 2,109 pg 432 U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded.

Table A.2 Incident rates of reported ESRD per per million population, by by age, gender, race, ethnicity, & primary diagnosis UNADJUSTED 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 0-4 2.8 7. 7. 8.1 9.8 9. 8.4 9.4 10.4 9.7 9. 10.8-9. 6.1 8.1 7. 7.3 7.1 8.8 6.8 6.9 6.9 6.1 6.0 10-14 9. 12.1 13.9 14.0 14.3 14.2 1.4 14.7 13.8 1.1 13.6 14.6 1-19 20.1 22.9 29.4 29.9 26.8 27. 26.9 28.4 29.3 28.1 30.4 28.3 20-29 36.1 47.3 63.4 69.0 67.0 66.9 62.0 60. 61.1 63. 64. 6. 30-39 67.4 8.9 113. 12.2 130.6 128.9 131.3 130.0 132.6 140.0 144.6 141.0 40-49 103.6 139.8 192. 230.9 249. 247.4 248.4 21.0 24.4 29.8 273.2 269.2 0-9 1.3 242.6 370.9 461.9 20. 27.1 22.6 31.1 32.0 37.7.8 48.4 60-64 201. 33.8 63. 767.4 896.3 91.0 891.4 897.3 892.9 89. 909.8 873.8 6-69 239.7 412.8 709.6 909.3 1,177.0 1,214.4 1,199.8 1,213.1 1,202.9 1,177.9 1,203.0 1,166.1 70-79 207.1 437.7 77.6 1,047.0 1,444.7 1,01.4 1,1.6 1,19.7 1,34.6 1,47.1 1,81.7 1,38.7 80-84 108.7 299. 602.0 907.7 1,474.6 1,490.7 1,62.4 1,618.8 1,639.3 1,704.2 1,719.0 1,718. 8+ 44.1 131.6 310.2 477.6 900.6 960.3 1,016.6 1,04.4 1,066.1 1,081. 1,088.4 1,101.0 0-19 10.2 12.4 14.6 14.6 14.6 14.6 1.0 14.9 1.2 1.1 1.1 1.1 20-44.6 73.4 103.3 118.7 122.9 121.7 120. 119.9 121.4 127.0 130. 128.9 4-64 16.2 249.4 370.4 46.3 14.6 20. 1.2 22.6 24.9 29.2 46.8 38. 6-74 232.8 432.4 736.7 970.2 1,270.3 1,321.0 1,309.2 1,306.9 1,314.3 1,300.1 1,327.9 1,291.1 7+ 129.8 314.2 98.7 869.3 1,33.2 1,391.1 1,461.3 1,47.2 1,482.8 1,13.8 1,29.6 1,06.1 Male 87. 139.8 219.1 277.8 34.9 364.9 373.0 377.1 389.1 398.6 413.3 410.3 Female 6.7 112.0 180. 239.1 298.4 304.6 304. 309.7 306.4 310.3 317.6 313.1 White 63.0 100.8 18.3 200.1 264.7 271.4 273.8 276.9 283.9 288.4 297.8 293.3 African American 179.8 301. 483.8 63. 72.9 743.8 77.9 772.9 78.6 776.8 789.9 783.4 Native American 86.7 177.0 291.0 362.0 404.6 390.8 376.8 368.0 386.3 386.0 376.4 381.7 Asian 27.1 101.9 18.4 230.4 264. 270.4 272.0 274. 277.1 287. 319.1 328.0 Hispanic 300.7 267.6 273.9 278.4 278.6 284.8 304.6 300.6 Non-Hispanic 329.8 344.2 348.1 33.1 38.3 36.4 37.1 371.8 Diabetes 11.4 3.8 70.9 106.9 14.6 149.9 149.4 11.6 13.9 1.9 161.6 18.4 Hypertension 13.6 34.2 60.9 69.6 87.4 90.8 93.2 96.4 96.1 96.7 98.9 100.8 Glomerulonephritis 12.0 21.0 27.7 30. 29.9 29.4 29.4 28.1 28.3 27.1 26.4 24.7 Cystic kidney 3.3.1 6.2 7.1 7.6 7.8 7.6 7.7 7.8 8.4 8.8 8.6 Other urologic 2.0 4.8.1 7. 9. 9. 10.0 9. 9.6 7.2..0 Other cause 7.9 14.7 19.2 26.3 31.6 32.1 33.8 34.4 36.2 41.2 4.6 46.4 Unknown cause 6.7 6.3 7. 9.1 13.0 13.7 13. 13. 13.6 1.6 16.1 1.3 Missing disease 19.4 3.7 1.9 1.0 1.6 1.0 1.3 1. 1.6 1.9 1.9 1.9 All 76.3 12. 199.3 28.0 326.1 334.2 338.2 342.8 347.1 33.8 364.7 361.0 Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded. on our website & cd Incident rates of reported ESRD: diabetes, hypertension, glomerulonephritis, & cystic kidney disease (A.2.1-4). Vol 3 esrd pg 433

Table A.2 (continued) Incident rates of reported ESRD per per million population, by by age, gender, race, ethnicity, & primary diagnosis ADJUSTED 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 0-4 2.7 7.3 7.4 7.9 9.6 9. 8.2 9.3 10.2 9. 9.4 10.4-9.4 6.1 7.9 7.3 7.2 7.0 8.7 6.7 6.9 6.8 6.1.9 10-14 9.2 12.2 13.7 13.6 13.9 13.8 1.0 14.4 13.6 14.7 13.3 14.6 1-19 19.8 22.7 28.6 28.8 26.0 26.6 26.2 27.3 28.0 26.9 29.3 27.3 20-29 36.7 47. 62.6 67.1 6.2 6. 60.6 9.2 9.8 61.7 62. 63.1 30-39 71.6 90.8 117.7 127.2 129.7 127.8 130.2 128.8 131.2 138.6 142.4 138.3 40-49 111.3 13.2 213.0 20.6 261.0 27. 27.6 28.8 261.1 264.9 277.0 271.7 0-9 171.2 270.8 412.2 19.7 81.1 87.2 7.9 81.8 79.2 80.6 9.9 8.7 60-64 22.3 408.7 634.9 847.4 967.8 996.6 970. 980.4 97.9 980.4 993.4 9.2 6-69 263.1 469.9 814.8 1,01.7 1,28.0 1,319.1 1,301.1 1,317.1 1,304.7 1,279.1 1,303.2 1,269.8 70-79 224.7 02.7 883.3 1,229.3 1,639.8 1,694.2 1,718.6 1,713.6 1,708.3 1,722.6 1,70.6 1,708.3 80-84 127.1 388.1 70.7 1,126.6 1,772.6 1,761.3 1,918.0 1,893. 1,912.4 1,977.9 1,986.9 1,977.8 8+ 9.6 19.9 439.7 66.2 1,191. 1,21.2 1,317. 1,347.8 1,349.0 1,366.3 1,362.9 1,388.7 0-19 9.3 12.1 14.4 14.4 14.1 14.2 14. 14.4 14.7 14. 14. 14. 20-44 62.7 81.2 108.7 119.0 119. 118.2 117.1 116.6 118.3 123.9 127.6 126.2 4-64 173.4 281.9 42.6 4.4 611.0 620.4 608. 613.6 611.8 613.0 627.7 610. 6-74 24.4 496.9 80.7 1,110.0 1,406.7 1,4.8 1,448. 1,442. 1,442.8 1,428.0 1,44.7 1,424.2 7+ 130.1 3.2 690.1 1,01.4 1,71.8 1,602.7 1,692.3 1,700.2 1,699.0 1,737. 1,748.3 1,734.9 Male 104.6 169.6 264.1 330.2 411.7 420.4 426.7 427.0 436.0 441.8 43.1 44.1 Female 70.1 117.7 18.1 240.8 287. 291.3 288.2 290. 28.1 286.0 290. 283.7 White 66.9 104.4 160.9 200.3 28.6 263.9 264.3 26.3 270.1 272.3 279.4 272.8 African American 248.9 418.6 66. 876.4 991.2 1,010. 1,020.2 1,028. 997.7 1,009.2 1,01.3 997.7 Native American 138.3 288.6 494.8 606.2 67.4 99.1 71.7 41.7 6.4 30.1 49.4 494. Asian 30.3 12.1 241.0 33. 378.1 376.2 376.3 368.7 361.9 367.2 393. 39. Hispanic 93.1 10.4 16.9 1.2 04.4 03. 24.1 08.4 Non-Hispanic 321.8 333.7 334.3 336.0 338.3 342.0 348.4 341.7 Diabetes 12.9 40.9 79.7 118.0 13.8 17.1 14.8 1.2 1.8 1.9 19.9 14.7 Hypertension 16. 39.6 67.8 7.6 91. 94.1 9.9 98.3 97.1 96.7 98.0 98.8 Glomerulonephritis 13.1 23.2 29.9 32.6 30.9 30.2 30.0 28. 28. 27.1 26.2 24.3 Cystic kidney 3.9.9 7.1 7.8 7.9 8.1 7.8 7.9 7.9 8.4 8.7 8. Other urologic 2.2.2. 7.9 9.8 9.8 10.2 9.7 9.7 7.2.4.0 Other cause 8.2 1.6 20.1 27.7 32. 32.8 34. 34.8 36. 41.2 4.4 4.7 Unknown cause 7.4 6.9 8.2 9.8 13. 14.2 13.8 13.8 13.8 1.6 16.0 1.0 Missing disease 22.0 4.0 2.1 1.1 1.7 1.1 1.3 1. 1.6 1.9 1.9 1.8 All 86.1 141.3 220.3 280.4 341. 347.4 348.3 349.6 30.7 33.8 361. 33.8 pg 434 Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender & age. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded.

Table A.3 Incident rates of reported diabetic ESRD per per million population, by by age, gender, race, & ethnicity UNADJUSTED 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 0-4. * * * * * * * * * * * -9.. *... *..... 10-14. * * *. * *. * * *. 1-19 0. * 0.8 * * * * * * * 0.6 0.6 20-29.3 12.6 1. 13.9 12.8 12.2 10.3 10. 10. 10.6 10.4 11.9 30-39 16.4 30.0 37.4 40.8 42.2 40.4 41.1 41.3 44.2 43.3 47. 47.3 40-49 17.8 46.4 74.8 93.6 102.4 100.7 101. 102.1 103.3 106.6 116.0 110.3 0-9 27.0 89.4 176.4 246.2 291.1 292.2 28.7 288.2 287.2 288.1 291.3 280. 60-64 32.2 119.6 262.7 420.3 20.6 41.9 14. 09.6 03.4 07.0 11. 487.6 6-69 29.4 121.9 283. 46.7 64.6 674.7 649.2 68.7 6.4 631.9 644.7 610.1 70-79 18.0 82.8 220.2 40.3 642.4 666.4 670.7 680.1 68.9 694.0 706.7 689. 80-84 * 34.9 100.6 212.6 442.6 473.7 1. 494.8 27.7 1.1 74.2 87.7 8+ * 6.4 3.6 77.4 187.1 207.4 218.0 231.8 238. 232.2 28.4 29.6 0-19 0.2 0.2 0.3 0.2 0.2 * 0.2 * * 0.2 0.2 0.2 20-44 11.0 23.4 32.8 36.9 38. 37. 36.1 37.2 38.0 38.9 42.3 41. 4-64 26.3 88.2 171.1 237.2 279.7 282.7 276.9 277.0 277.3 278.9 284.4 27.4 6-74 2.7 109.6 269.3 42.7 64.0 681. 666.9 671.1 671.8 662.9 677.1 60.1 7+ 7.7 43.6 122.2 240.4 4.1 477.3 496.2 00. 12. 17.9 32.0 2. Male 12.3 36.0 67.8 102. 146. 12. 14.8 17.7 164.6 168.1 17.2 173.4 Female 10.6 3. 74.0 111.1 144.8 147. 144.2 14.7 143.6 144.0 148.4 143.9 White 9.6 28.6 6.1 82.9 118.3 120.9 120.0 122.1 12.3 126.4 131.1 128.8 African American 24. 83.9 168.0 23.8 311. 327.4 329.9 333.2 327.9 33.1 343.1 333.0 Native American 3.7 109.4 193.3 261.3 298.8 280.4 273.0 271. 280.7 261.8 21.3 26. Asian * 28.0.4 99.7 124.9 129.6 12.9 127. 132.4 137.2 1.1 11.6 Hispanic 178.4 161.9 163.7 168.9 169.2 168.4 178.4 176.8 Non-Hispanic 140.9 148.1 147.2 148.9 11.4 13.8 18.7 1.1 All 11.4 3.8 70.9 106.9 14.6 149.9 149.4 11.6 13.9 1.9 161.6 18.4 ADJUSTED 0-4. * * * * * * * * * * * -9.. *... *..... 10-14. * * *. * *. * * *. 1-19 0. * 0.8 * * * * * * * 0. 0.6 20-29.3 12.4 14.9 13. 12.7 12.1 10.4 10. 10. 10. 10.2 11. 30-39 16.1 30.2 37. 40.8 41.9 40.1 40.9 41.1 44.0 43.0 47.0 46.6 40-49 18.9 0.2 81.8 100.4 106.7 104.3 10.0 104.9 10.6 108.3 117.1 111.1 0-9 30.6 101.0 196.1 277.6 324.9 326.3 31. 31.7 312.0 310. 311.3 298. 60-64 36.8 141.6 298. 466.4 61.3 90.0 60.7 6.8 49.7 4.7 7.9 30.6 6-69 34.1 144.6 332.7 1.8 707.0 73.7 704.8 71.8 712.9 686. 698.8 663.3 70-79 19.2 100.0 27.7 480.6 729.9 74.6 763.1 769.7 76.8 774.6 781.0 76.0 80-84 * 2.1 129.0 276.3 40.4 66. 627.0 87.6 629.1 649.3 67. 682.1 8+ * 11.1 4. 111.0 27.7 276.4 28.6 297.8 31. 302.4 329.7 33. 0-19 0.1 0.2 0.3 0.2 0.2 * 0.2 * * 0.2 0.2 0.2 20-44 11.9 2.0 33.7 36.3 37.1 36.1 34.9 36.0 36.9 37.9 41.4 40.7 4-64 29.8 101.0 197.7 287.3 337.1 343.8 332. 330.3 327.3 327. 330.6 31. 6-74 28.8 129.7 314. 21. 72.6 73.1 738.9 740. 737.2 726.3 739.7 71.2 7+ 6.1 49. 134.2 273.7 04. 27.2.3 3.2 71.6 78.3 9. 93. Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Male 14.3 43.2 81.3 121.6 168.1 173.9 174.9 176.0 181.7 183.2 188.8 184.6 Female 11.6 38. 77.8 114.6 141.9 143.2 138.3 138.2 134.8 133.6 136.3 130. White 10.3 29.7 7. 83.8 116.4 118. 116.6 117. 119.6 119.6 123.2 119.6 African American 34.0 118.9 240.2 36.0 438.2 47.7 46.6 43. 440.2 443.7 447.8 429.1 Native American 60.8 187. 337.1 41.3 483.6 438.1 417.9 403.0 404.8 39.8 330.8 333.4 Asian * 48.0 89.2 19.6 184.0 18.7 176.9 173.4 176.4 176.1 193.8 18. Hispanic 363.3 323.4 32.0 326.1 320. 311.9 321.0 311.9 Non-Hispanic 138.0 144.1 141.6 141.6 142.7 143.4 146.7 141.7 All 12.9 40.9 79.7 118.0 13.8 17.1 14.8 1.2 1.8 1.9 19.9 14.7 Rates by age are adjusted for gender & race, rates by gender are adjusted for age & race, rates by race & ethnicity are adjusted for gender & age. U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded. Vol 3 esrd pg 43

Table A.3 (continued) Incident rates of reported diabetic ESRD:CDC diabetic population per per million population, by by age, gender, race, & ethnicity UNADJUSTED 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 0-44 988 2,207 2,99 2,724 1,873 1,762 1,717 1,762 1,60 1,496 1,06 4-64 481 1,79 3,084 3,932 3,367 3,232 3,03 2,964 2,826 2,728 2,772 6-74 28 1,090 2,736 4,20 4,378 4,260 3,992 3,847 3,724 3,604 3,71 7+ 97 48 1,96 2,73 3,927 3,891 3,792 3,600 3,98 3,476 3,1 Male 6 1,47 2,848 3,668 3,464 3,322 3,227 3,139 3,149 3,076 3,174 Female 392 1,226 2,3 3,49 3,381 3,314 3,113 3,029 2,784 2,94 2,86 White 406 1,130 2,198 2,974 2,979 2,848 2,660 2,7 2,473 2,384 2,414 African American 72 2,308 4,74,919,912,928,929,727,362,006,013 Other 88 3,70 4,080 3,864 2,77 2,2 2,732 2,916 3,313 2,817 3,067 Hispanic 4,602 4,077 4,070 4,02 3,888 3,9 3,832 Non-Hispanic 3,268 3,220 3,04 2,960 2,841 2,723 2,737 All 464 1,36 2,672 3,4 3,421 3,318 3,170 3,084 2,96 2,830 2,870 ADJUSTED 0-44 1,014 2,27 2,760 2,862 1,919 1,774 1,700 1,743 1,631 1,448 1,46 4-64 478 1,670 3,144 3,79 3,318 3,20 3,061 2,91 2,787 2,692 2,746 6-74 326 1,208 2,86 4,469 4,00 4,33 4,10 3,93 3,89 3,64 3,71 7+ 104 1 1,949 2,702 4,141 4,207 4,16 3,967 3,867 3,773 3,814 Male 36 1,624 2,92 3,739 3,609 3,467 3,377 3,24 3,239 3,170 3,280 Female 408 1,36 2,700 3,380 3,307 3,237 3,00 2,99 2,734 2,37 2,0 White 420 1,180 2,214 3,011 2,949 2,801 2,60 2,21 2,428 2,31 2,400 African American 708 2,331 4,902,83 6,198 6,343 6,384 6,022,11,272,327 Other 496 3,067 4,926 4,814 2,926 2,897 3,029 3,221 3,72 2,989 3,189 Hispanic 4,843 4,168 4,296 4,226 4,180 3,878 4,1 Non-Hispanic 3,260 3,209 3,029 2,923 2,809 2,706 2,737 All 472 1,484 2,809 3,4 3,442 3,339 3,196 3,088 2,968 2,830 2,894 pg 436

Table A.4 Incident counts of reported ESRD patients, 200-2007 combined by age & primary diagnosis Incident counts of reported ESRD patients, 200 2007 combined Male Female All White Af Am N Am Asian All White Af Am N Am Asian All White Af Am N Am Asian All 0-4 293 7 13 29 410 147 38 * 12 203 440 113 19 41 613-9 134 40 * 27 204 124 26 * 18 170 28 66 * 4 374 10-14 330 107 * 27 474 304 86 * 19 41 634 193 16 46 889 1-19 660 306 18 64 1,048 491 234 24 47 796 1,11 40 42 111 1,844 20-29 2,23 1,9 61 238 4,381 1,829 1,3 9 214 3,6 4,32 3,112 120 42 8,036 30-39,13 4,266 16 469 10,03 3,461 3,334 146 389 7,330 8,96 7,600 311 88 17,36 40-49 11,980 8,41 339 903 21,763 7,36 6,180 233 646 14,424 19,34 14,721 72 1,49 36,187 0-9 22,126 12,469 481 1,618 36,694 14,941 9,910 469 1,073 26,393 37,067 22,379 90 2,691 63,087 60-64 13,460,334 217 884 19,89 10,290,382 216 647 16,3 23,70 10,716 433 1,31 36,430 6-69 14,077 4,734 229 867 19,907 10,868,288 233 644 17,033 24,94 10,022 462 1,11 36,940 70-79 31,48 6,934 227 1,440 40,09 23,0 9,047 316 1,413 34,281 4,963 1,981 43 2,83 74,340 80-84 13,320 1,890 0 1,81 9,906 2,820 82 22 13,330 23,226 4,710 137 1,072 29,14 8+ 7,877 98 21 31 9,198,96 1,74 2 36 8,091 13,833 2,730 46 680 17,289 0-19 1,417 28 44 147 2,136 1,066 384 38 96 1,84 2,483 912 82 243 3,720 20-44 12,30 9,61 392 1,063 23,46 8,238 7,07 304 869 16,918 20,768 17,068 696 1,932 40,464 4-64 42,694 22,608 871 3,049 69,222 29,648 18,82 819 2,100 1,419 72,342 41,460 1,690,149 120,641 6-74 29,28 8,730 33 1,634 40,002 22,422 10,130 427 1,348 34,327 1,707 18,860 780 2,982 74,329 7+ 37,447,813 179 1,38 44,977 27,813 8,770 229 1,96 38,408 6,260 14,83 408 3,134 83,38 Diabetes 2,6 18,693 1,193 3,97 76,048 40,811 21,272 1,266 2,78 66,134 93,376 39,96 2,49 6,382 142,182 Hypertension 31,200 17,67 238 1,68 0,690 21,480 14,813 192 1,372 37,87 2,680 32,380 430 3,07 88,47 Glomerulonephritis 9,886 3,380 13 839 14,28,788 2,446 123 69 9,02 1,674,826 276 1,34 23,310 Other cause 29,722 7,600 2 1,310 38,887 21,108 7,112 236 1,17 29,613 0,830 14,712 491 2,467 68,00 All 123,373 47,240 1,839 7,431 179,883 89,187 4,643 1,817 6,009 142,66 212,60 92,883 3,66 13,440 322,39 2009 USRDS Annual Data Report Section A 4 Incidence of reported ESRD U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded. on our website & cd Incident counts of reported ESRD patients for previous three-year period (A.4.1). Incident counts of reported ESRD: by primary diagnosis (A.4.2). Vol 3 esrd pg 437

Table A. Incident rates of reported ESRD, 200 2007 200-2007 combined per per million population, by by age & primary diagnosis Unadjusted rates Rates adjusted for: Male Female Gender Race Gender & White Af Am N Am Asian White Af Am N Am Asian White Af Am N Am Asian Male Female race 0-4 12 1 39 18 6 8 * 8 9 11 29 13 13 7 10-9 6 8 * 19 6 6 * 13 6 7 * 16 7 6 6 10-14 13 21 * 19 13 17 * 14 13 19 19 16 1 14 14 1-19 26 8 39 44 20 46 3 34 23 2 46 39 31 2 28 20-29 0 171 71 72 39 168 74 6 44 171 74 68 67 7 62 30-39 104 49 237 121 73 386 221 96 88 46 229 108 164 116 140 40-49 217 1,067 498 282 134 676 332 187 174 871 414 237 33 210 271 0-9 466 2,131 98 687 306 1,416 871 39 389 1,799 934 47 711 470 87 60-64 797 3,098 1,416 1,189 69 2,441 1,286 76 682 2,768 1,37 967 1,127 833 976 6-69 1,116 3,687 2,133 1,27 768 3,043 1,942 979 939 3,360 2,039 1,248 1,48 1,090 1,284 70-79 1,711 4,21 1,811 2,04 1,010 3,6 2,037 1,48 1,366 3,90 1,927 1,79 2,080 1,38 1,727 80-84 2,263 4,333 1,760 2,87 1,064 3,410 1,790 1,8 1,64 3,86 1,784 2,36 2,9 1,419 1,981 8+ 1,73 2,93 887 2,191 614 2,126 11 1,32 1,166 2,21 697 1,83 1,90 8 1,373 0-19 14 26 27 2 11 19 24 17 13 22 2 21 16 13 1 20-44 98 46 206 120 68 333 168 9 81 402 196 106 149 104 126 4-64 463 1,967 884 663 313 1,37 777 402 417 1,842 919 89 73 0 617 6-74 1,292 3,870 1,94 1,671 84 3,213 2,037 1,133 1,084 3,61 1,978 1,421 1,679 1,200 1,436 7+ 1,996 4,023 1,687 2,47 922 3,16 1,428 1,699 1,441 3,478 1,472 2,068 2,20 1,24 1,740 Diabetes 146 330 249 172 112 343 264 126 121 440 341 18 30 221 262 Hypertension 87 310 0 80 9 239 40 62 67 360 67 94 264 10 206 Glomerulonephritis 28 60 32 40 16 39 26 31 21 7 33 39 47 2 3 Other cause 83 134 3 63 8 11 49 2 13 30 13 13 31 18 24 All 344 83 384 3 244 737 378 272 293 783 381 312 407 314 360 All (age adjusted) 3 1,164 32 472 214 870 484 314 27 1,007 07 38 447 287 36 pg 438 on our website & cd Incident rates of reported ESRD for previous three-year period (A..1). Incident rates of reported ESRD: by primary diagnosis (A..2).

Table A.6 Mean age at start of ESRD therapy by by age, age, gender, race, ethnicity, primary diagnosis, & location 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 0-4 2. 1.8 1.7 1.8 1.6 1.7 1.7 1.7 1.6 1.6 1.4 1.6-9 8.0 7.6 7.8 7. 7.6 7.6 7.6 7.6 7.8 7.6 7.7 7.7 10-14 12.6 12.9 12.7 12.8 12.6 12.8 12.8 12.8 13.0 12.9 13.0 12.9 1-19 17.7 17.8 17.8 17.7 17.9 17.8 17.8 17.7 17.7 17.7 17.8 17.7 20-29 2. 2.8 2.9 2.8 2.9 2.8 2.7 2.6 2.7 2. 2.7 2.6 30-39 34.9 3.2 3.3 3. 3. 3. 3.6 3. 3.6 3. 3.6 3.6 40-49 4.3 4.2 4.1 4.3 4. 4. 4.6 4.6 4. 4. 4.6 4.6 0-9.3..4.3.2.2.3.2.3.3.3.4 60-64 62. 62.6 62.6 62.6 62.6 62.6 62. 62. 62. 62. 62.6 62. 6-69 67.4 67. 67. 67. 67. 67. 67.6 67. 67. 67. 67. 67. 70-79 74.1 74.3 74. 74.6 74.9 74.9 74.9 7.0 7.0 7.0 7.0 74.9 80-84 82.1 82.1 82.1 82.2 82.2 82.2 82.3 82.3 82.3 82.3 82.3 82.3 8+ 87.7 87.8 87.9 87.8 88.0 88.1 88.2 88.1 88.2 88.1 88.1 88.1 0-19 14.3 13.0 13.1 13.0 12.7 12.7 12.8 12.9 12.7 12.8 13.1 12.6 20-44 33.7 34.2 3.1 3.7 36.1 36.1 36.2 36.2 36.2 36.2 36.3 36.2 4-64 6.0 6.6 6. 6.1 6.0 6.0 6.0 6.0 6.1 6.1 6.1 6.2 6-74 69. 69.8 69.8 70.0 70.1 70.1 70.1 70.1 70.1 70.0 70.0 70.0 7+ 79.2 79.6 80.1 80.3 80.8 80.9 81.1 81.1 81.2 81.3 81.3 81. Male 2.4.3 7. 9.0 61. 61.7 62.1 62.1 62.2 62.3 62.2 62.4 Female 3.3 6.9 9.2 61.0 63.1 63.3 63.6 63. 63.4 63.4 63. 63.3 Unknown 0.3 4.3. 3.4 44.8.. 72.8. 71.1 70.6 61.0 White 3.1 6.8 9.8 62.0 64.3 64. 64.9 6.0 6.0 6.0 64.9 6.0 African American 2.2 4.6.4 6.1 8.2 8.4 8.6 8.6 8.4 8.4 8. 8.7 Native American 49.9 3.6.7 6.2 7.8 6.6 7.6 7.9 8. 6.9 6.1 6.6 Asian 41.7 2.6.8 9.8 61.4 61.4 62.0 61.9 61.8 62.0 60.9 60.0 Other/unknown.3 0.7 47.8 7.1.7.6.2.0 3.2 3.0 0.8 2.0 Hispanic 9.0 8. 8.7 8.7 8. 8.6 8.4 8. Non-Hispanic 62.7 63.0 63.3 63.4 63.4 63.4 63.4 63. Diabetes 1.0.0 8.4 60.7 62.8 63.1 63.3 63.3 63.3 63.3 63.2 63.3 Hypertension 6.2 61.9 64.0 6.2 67.1 67.2 67.6 67. 67. 67.4 67.4 67.1 Glomerulonephritis 44.8 0.2 1.3 2.7 3.8 3.6 4.1 3.8 3.3 3.6 3.7 3.4 Cystic kidney 1. 3.6 4.2 4.1.1.0.2 4.4 4.8 4.9.2 4.8 Other urologic 1.3 8.3 8.8 9.7 62.3 62.3 61.7 63.0 63.0 62. 63.0 62.6 Other cause 47.2 1.0 1.6 2.8.7 6.0 6.8 6.8 7.3 7.8 8.3 8. Unknown cause.2 9.3 9.6 62.2 63.8 63. 63.1 63.4 62.9 63.3 62.6 63.0 Missing disease 8.0 61.4 3.0 2.1 1.0 49.6 6.4.9 6.4 7.1 9.6 9.2 U.S. 2.8 6.1 8.4 60.0 62.3 62. 62.8 62.8 62.8 62.8 62.8 62.9 U.S. territories 48.2 2.4 3.6.0 8.8 8.7 7.0 8.4 7. 60.3 8.8 4.8 Puerto Rico 4. 6.2 7.3 8.0 60.0 60.7 60.8 61.4 60.6 61.1 61.6 62.2 Foreign 3.7 0. 49.9 49.1.3 66.2 8.0 68.7 66.6 73.9 71.8 70.2 Unknown 4.9 42.9 47.7 42. 46.3 43.0 43. 41.7 4.8 46.6 47.2 47.7 All 2.8 6.1 8.3 60.0 62.2 62. 62.7 62.8 62.7 62.8 62.8 62.8 Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Patients with unknown age are excluded. on our website & cd Median age at start of ESRD therapy; incident patients by demographic characteristics & primary diagnosis (A.c). Vol 3 esrd pg 439

Table Table A.7 A.7 Incidence of reported ESRD, by primary diagnosis, 2003-2007 combined by detailed by primary diagnosis Incidence of reported ESRD, by primary diagnosis, 2003 2007 combined Total Percent Median Age Percent Percent % Tx % Died ROW PERCENT patients incident age 0-19 20-64 6+ male White Af Am N Am Asian 1st yr 1st yr All ESRD, (reference) 36,877 100.0 64 1.2 11.2 49.0.4 6.3 28.4 1.1 4.0.0 23.7 Diabetes 237,863 44.7 63. 14.3 47.0 3.0 6.3 27.6 1.8 4.3 2.7 22.2 Diabetes with renal manifestations, Type 2 216,676 40.7 64. 14.9 49.7 2.8 64.7 28.0 1.8 4. 1.7 22.9 Diabetes with renal manifestations, Type 1 21,187 4.0 49 0.1 8.1 19.7 4.7 71.3 24.1 1.2 2.6 12.9 1.8 Glomerulonephritis 39,189 7.4 3 4.0 8.2 30. 61.6 66.2 2.0 1.1 6.3 14.3 11.7 Glomerulonephritis (GN; histologically not examined 1,206 2.9 8 1.9 8.3 38. 61.6 66.3 23.7 1.1 7.1 9.0 14.8 Focal glomerulosclerosis, focal sclerosing GN 11,94 2.2 0 6.9 8.0 23.6 61.6 7.8 37.2 0.7 3.4 16. 8. Membranous nephropathy 2,308 0.4 8 1. 10.7 36. 64.6 67.9 27.3 0.6 3.2 11.4 11.8 Membranoproliferative GN type 1, diffuse MPGN 1,648 0.3 3 4.8 8.6 26.1 60.1 74.7 17.9 1.1.4 1.7 12.9 Dense deposit disease, MPGN type 2 137. 46 19.0 2.2 19.0 9.1 84.7 9. 0.7 3.6 18.2 10.2 IgA nephropathy, Berger's (by immunofluorescence 4,328 0.8 44 3.0.8 14. 67.4 7.0 6.4 1.9 1.4 30.7 4.6 IgM nephropathy (by immunofluorescence) 362 0.1 4 2.2 6.4 19.3 9.4 69.3 11.6 2.2 14.9 29.8 6.6 With lesion of rapidly progressive GN 1,37 0.3 63 4.9 9.7 46.0 1.3 81.2 12.6 1.3 3.6.3 20.9 Post-infectious GN, SBE 497 0.1 8 2.8 9.3 36.8 64.6 81.1 12. 2.6 3.4 7.6 21.1 Other proliferative GN 1,401 0.3 6.9 9.7 33. 0.8 74.9 19. 1.4 3.3 11.3 1.2 Secondary GN/vasculitis 11,69 2.2 48 6.3 7.1 24.0 33.6 62. 31.3 1.2 4.0 7. 17.9 Lupus erythematosus (SLE nephritis),667 1.1 38 7.2 4.0 7.1 19.2 41. 0.0 1.3.9 9.2 12.2 Henoch-Schonlein syndrome 116. 43 19.8 4.3 19.8 6. 87.1.2 0.9 6.9 27.6 13.8 Scleroderma 708 0.1 6 0.7 12.4 28.8 23.7 76.1 20.2 1.1 2.0 2.4 36.0 Hemolytic uremic syndrome 728 0.1 46 16.9 6.3 18.4 37.1 76.4 20.2 0. 1.6 9. 16.9 Polyarteritis 277 0.1 67 4.3 9.7 4.2 44.8 83.4 9.0 2. 4.3 4.0 22.7 Wegener's granulomatosis 1,639 0.3 64 3.7 11.7 49..7 91.3.2 1.3 1.7 6.1 21.8 Nephropathy due to heroin abuse and related drug 200. 46. 3.0 6.0 71. 44. 2. 1.0 0. 0. 19.0 Other vasculitis and its derivatives 1,142 0.2 66.2 10.2 3.4 4.6 84.2 11.1 1.2 2.8 4.8 26.4 Goodpasture's syndrome 636 0.1 9 4.2 11.2 38.2 47. 89.8 7. 0. 1.9.7 19.8 Secondary GN, other 46 0.1 7 2.9 7.7 37. 6.4 71.1 23.3 1.1 3.1 6.2 22.7 Interstitial nephritis/pyelonephritis 17,11 3.3 6 2.3 10.8 1.1 8.2 82.4 13.0 0.6 3.2 7. 24.0 Analgesic abuse 888 0.2 67 0.3 10.2.6 42.3 83.4 12.3 0. 3.3 4.8 20. Radiation nephritis 243. 66 0.8 16.9 2.7 44.9 90. 8.2. 1.2 8.6 34.2 Lead nephropathy 3. 6 2.9 17.1 1.4 74.3 40.0 4.3..7.7 20.0 Nephropathy caused by other agents 2,79 0. 62 1.4 13.8 44.1.0 83.1 13.0 0.6 2. 7.6 27. Gouty nephropathy 23. 63 0.4 11.1 46.8 78.7 7.9 20.4 0.4 19.1 7.7 23.4 Nephrolithiasis 891 0.2 6 1.0 11.3 0.4 2.9 81.7 10.4 0.7 6.3 6.4 19.8 Acquired obstructive uropathy,090 1.0 70 1.0 10.8 63.0 77.2 81.9 14.6 0.9 1.9 2.2 29.9 Chronic pyelonephritis, reflux nephropathy 1,82 0.3 46 11.0 6.0 24.7 42.3 86.1 8.1 0.8 4.0 23.3 10.7 Chronic interstitial nephritis 3,92 0.7 6 1.9 10.3 1.6 49.6 81.9 13.2 0. 3.7 9.2 20.9 Acute interstitial nephritis 1,170 0.2 66 0.3 11.7 4.2 2.9 83.6 13. 0.3 2.2 1.8 26.8 Urolithiasis 203. 64 1.0 9.4 48.3 2.7 79.3 10.8. 7.9.9 16.7 Other disorders of calcium metabolism 220. 64 2.3 14.1 46.8. 83.6 13.6. 2.7 10.9 19. Hypertensive/large vessel disease 146,78 27. 70 0.2 8.4 61.8 6.9 9.3 36.1 0.4 3. 2.1 26.1 Unspecified with renal failure 13,072 2.4 69 0.2 8. 9.9 7.1 6.6 38.7 0.4 3.6 2.2 2. Renal artery stenosis 7,089 1.3 76 0.1 7.2 8.1 1.1 90.7 7.3 0.3 1. 1.1 34.0 Renal artery occlusion 1,16 0.3 74 0.7 7.4 77.8 4.7 89.6 7.8 0.3 1.9 1.2 34.0 Cholesterol emboli, renal emboli 2,901 0. 7. 8.1 86.1 64.2 94.3 3. 0.3 1.6 0.6 33.0 Cystic/heriditary/congenital diseases 16,890 3.2 1 12. 8.1 19.6 6.9 80. 13.8 0.7 4.0 29.0 6.1 Polycystic kidneys, adult type (dominant) 11,948 2.2 4 0.3 10.2 23.1 3.9 81.7 13.4 0.4 3.9 2.9.7 Polycystic, infantile (recessive) 2. 16.3 2.7 3.9 3.7 74.1 18.0 0.8 2.7 44.7.1 Medullary cystic disease, including nephronophthis 244. 26 39.3 2.0 13.1 43.4 84.8 6.1 1.6.7 1.6 4. Tuberous sclerosis 196. 61 4.6 7.1 43.9 42.9 78.6 17.9. 2.0 6.6 24.0 Hereditary nephritis, Alport's syndrome 777 0.1 37 17.1.4 10.2 68.3 8.6 9.0 0.6 4.0 38.0 2.1 Cystinosis 93. 1 6.6 2.2 8.6 48.4 89.2 6. 2.2 2.2 62.4 4.3 Primary oxalosis 2. 42 32.7 3.8 19.2 3.8 73.1 13. 3.8 7.7 34.6 11. Fabry's disease 103. 4. 1.0 7.8 81.6 86.4 10.7. 2.9 3.0 7.8 Congenital nephrotic syndrome 318 0.1 27 42.1 2.2 12.3 6.9 67.9 24. 0.6.3 33.6 11.3 Drash syndrome, mesangial sclerosis 62. 4 2.8 6. 30.6 61.3 7.8 16.1. 3.2 8.1 16.1 Congenital obstruction of ureterpelvic junction 170. 26 38.8 4.1 10.6 71.2 74.1 18.2 2.4 2.9 30.6 9.4 Congenital obstruction of uretrovesical junction 78. 28 32.1 2.6 12.8 79. 7.6 1.4 2.6.1 42.3 7.7 Other congenital obstructive uropathy 1,062 0.2 23 44.3 2.2 12.3 76.1 73.1 18.6 1.8 4.3 32.1 8.9 Renal hypoplasia, dysplasia, oligonephronia 994 0.2 13 72.2 1.3.0 9.9 7.3 14.6 1.7.1 41.1 4.4 Prune belly syndrome 120. 11 73.3. 2. 9.8 74.2 20.0 1.7 2. 47. 2. Other (congenital malformation syndromes) 418 0.1 37 24.4.0 11.2.3 84.0 11. 1.7 2.6 33.7 7.7 pg 440 on our website & cd Incidence of reported ESRD, by primary diagnosis: Hispanic & non-hispanic patients (A.7.1-2). Incidence of reported ESRD: by detailed primary diagnosis, age <20, 20-64, & 6+ (A.7.3-).

Table Table A.7 A.7 (continued) Incidence of reported ESRD, by primary diagnosis, 2003-2007 combined by detailed by primary diagnosis Incidence of reported ESRD, by primary diagnosis, 2003 2007 combined Total Percent Median Age Percent Percent % Tx % Died ROW PERCENT patients incident age 0-19 20-64 6+ male White Af Am N Am Asian 1st yr 1st yr Neoplasms/tumors 12,870 2.4 68 0.9 13.0 8.0 62.1 79.7 17.3 0.6 2.0 2.7 46. Renal tumor (malignant) 2,011 0.4 69 2.0 11.9 62. 71.2 83.1 14. 0.7 1.3 1.4 31.6 Urinary tract tumor (malignant) 698 0.1 74 0.1 10.7 73. 84.2 83.2 13.8 0.6 2.0 0.3 4.0 Renal tumor (benign) 83. 68 1.2 10.8 7.8 63.9 80.7 1.7. 2.4 4.8 18.1 Urinary tract tumor (benign). 68. 7.3 61.8 90.9 83.6 16.4.. 1.8 27.3 Renal tumor (unspecified) 230. 71 1.7 8.7 6.2 6.7 80.0 17.0 0.4 1.7 3.9 28.3 Urinary tract tumor (unspecified) 134. 73. 11.2 72.4 77.6 78.4 1.7 0.7 1. 1. 47.0 Lymphoma of kidneys 192. 66. 1.6.2 70.3 82.8 1.6 0. 0. 0. 6.8 Multiple myeloma,821 1.1 69. 12. 63.4.2 76.0 21. 0. 1.7 0.1 9.0 Other immuno prolif. neoplasms (inc. light chain ne 686 0.1 69 0.3 12.1 60.8 9.6 82.9 14.3 0.7 1. 0.9 41.1 Amyloidosis 1,33 0.3 66 0.2 13.9 4.1 8.6 81.0 1.4 0. 2. 2. 41.6 Complications of transplanted organ, unspecified 40. 7. 12. 2.0 7. 82. 2.. 12. 17. 12. Complications of transplanted kidney 79. 48 3.8 6.3 13.9 6.8 74.7 7.6 1.3 16. 34.2 1.2 Complications of transplanted liver 860 0.2 7 2.7 16.9 24.0 63. 86.0 9.8 0.8 2.7 16.2 26.3 Complications of transplanted heart 409 0.1 61.4 19.3 37.2 77. 83.1 13.9 0. 2.4 13.2 27.6 Complications of transplanted lung 108. 9 0.9 21.3 24.1 2.8 92.6.6. 1.9 14.8 32.4 Complications of transplanted bone marrow 9. 4 22.0 16.9 10.2 62.7 84.7 11.9. 3.4 11.9 37.3 Complications of transplanted pancreas 46. 9 4.3 19.6 26.1 60.9 71.7 13.0 2.2 10.9 10.9 30.4 Complications of transplanted intestine *. 46 33.. 67 67 33.... Complications of other specified transplanted organ 21. 7 14.3 4.8 33.3 81.0 8.7 9.. 4.8 19.0 28.6 Miscellaneous conditions 27,47.2 62 1. 9.1 44.8 60.3 68.6 28.1 0. 2.0 4.7 37.2 Sickle cell disease/anemia 499 0.1 43 2.8 2.8 4.8 2.7 2.0 97.2. 0.4 2.2 29.1 Sickle cell trait and other sickle cell (HbS/Hb other) 29. 48 3.4 6.9 10.3 41.4. 100.0... 20.7 Post-partum renal failure 104. 29 9.6 1.0. 2.9 8.7 33.7. 4.8 9.6 2.9 AIDS nephropathy 4,208 0.8 43 1.1 2.9 2.9 6.3 10.8 87.7 0.2 0.2 0.2 30.8 Traumatic or surgical loss of kidney(s) 87 0.1 64 2.7 12.3 49.9 63.9 81.6 1.2 0. 1.9 4.9 21.1 Hepatorenal syndrome 2,18 0.4 0.2 13.3 21.6 67.6 81. 12.4 1.6 3.7 21.2 7.4 Tubular necrosis (no recovery) 13,047 2. 69 0.9 10.4 9.3 7.7 81.3 1.7 0. 1.8 0.8 39.4 Other renal disorders 6,82 1.3 66 2.9 9.4 3. 61.2 80.1 1.8 0. 3.1 9.7 33.0 Etiology uncertain 22,293 4.2 66 3.0 8.4 3.2 8.1 72.3 21.2 0.8 4.6.4 29.6 Missing 4,67 0.9 9 4.7 9.8 39.3 7.0 4.7 21. 1.0.2 37.1 29.4 Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Vol 3 esrd pg 441

Table A.7 (continued) Incidence of reported ESRD, by primary diagnosis, 2003 2007 2003-2007 combined by detailed primary diagnosis Total Counts Percent COLUMN PERCENT patients White Af Am N Am Asian White Af Am N Am Asian All ESRD, (reference) 36,877 30,822 12,439 6,040 21,67 100.0 100.0 100.0 100.0 Diabetes 237,863 1,301 6,760 4,179 10,321 44. 43.4 69.7 48.2 Diabetes with renal manifestations, Type 2 216,676 140,186 60,60 3,920 9,761 40.2 40.0 6.4 4.6 Diabetes with renal manifestations, Type 1 21,187 1,11,110 29 60 4.3 3.4 4.3 2.6 Glomerulonephritis 39,189 2,962 9,811 420 2,48 7.4 6. 7.0 11.6 Glomerulonephritis (GN; histologically not examined) 1,206 10,089 3,60 163 1,084 2.9 2.4 2.7.1 Focal glomerulosclerosis, focal sclerosing GN 11,94 6,909 4,442 86 401 2.0 2.9 1.4 1.9 Membranous nephropathy 2,308 1,66 630 13 73 0.4 0.4 0.2 0.3 Membranoproliferative GN type 1, diffuse MPGN 1,648 1,231 29 18 89 0.4 0.2 0.3 0.4 Dense deposit disease, MPGN type 2 137 116 13 * *.... IgA nephropathy, Berger's (by immunofluorescence) 4,328 3,24 278 81 667 0.9 0.2 1.4 3.1 IgM nephropathy (by immunofluorescence) 362 21 42 * 4 0.1. 0.1 0.3 With lesion of rapidly progressive GN 1,37 1,102 171 18 49 0.3 0.1 0.3 0.2 Post-infectious GN, SBE 497 403 62 13 17 0.1. 0.2 0.1 Other proliferative GN 1,401 1,00 273 19 46 0.3 0.2 0.3 0.2 Secondary GN/vasculitis 11,69 7,284 3,646 137 472 2.1 2.4 2.3 2.2 Lupus erythematosus (SLE nephritis),667 2,31 2,833 71 336 0.7 1.9 1.2 1.6 Henoch-Schonlein syndrome 116 101 * * *.... Scleroderma 708 39 143 * 14 0.2 0.1 0.1 0.1 Hemolytic uremic syndrome 728 6 147 * 12 0.2 0.1 0.1 0.1 Polyarteritis 277 231 2 * 12 0.1. 0.1 0.1 Wegener's granulomatosis 1,639 1,497 8 21 28 0.4 0.1 0.4 0.1 Nephropathy due to heroin abuse and related drugs 200 89 10 * *. 0.1.. Other vasculitis and its derivatives 1,142 961 127 14 32 0.3 0.1 0.2 0.1 Goodpasture's syndrome 636 71 48 * 12 0.2. 0.1 0.1 Secondary GN, other 46 388 127 * 17 0.1 0.1 0.1 0.1 Interstitial nephritis/pyelonephritis 17,11 14,431 2,269 110 69 4.1 1. 1.8 2.7 Analgesic abuse 888 741 109 * 29 0.2 0.1 0.1 0.1 Radiation nephritis 243 220 20. * 0.1... Lead nephropathy 3 14 19. *.... Nephropathy caused by other agents 2,79 2,293 360 16 68 0.7 0.2 0.3 0.3 Gouty nephropathy 23 136 48 * 4... 0.2 Nephrolithiasis 891 728 93 * 6 0.2 0.1 0.1 0.3 Acquired obstructive uropathy,090 4,168 741 4 97 1.2 0. 0.8 0. Chronic pyelonephritis, reflux nephropathy 1,82 1,9 10 14 74 0. 0.1 0.2 0.3 Chronic interstitial nephritis 3,92 3,213 19 21 147 0.9 0.3 0.4 0.7 Acute interstitial nephritis 1,170 978 18 * 26 0.3 0.1 0.1 0.1 Urolithiasis 203 161 22. 16... 0.1 Other disorders of calcium metabolism 220 184 30. * 0.1... Hypertensive/large vessel disease 146,78 86,949 2,96 641,07 24.9 3.0 10.7 23.6 Unspecified with renal failure 13,072 76,427 2,226 603 4,873 21.9 34. 10.1 22.8 Renal artery stenosis 7,089 6,428 19 24 108 1.8 0.3 0.4 0. Renal artery occlusion 1,16 1,38 118 * 29 0.4 0.1 0.1 0.1 Cholesterol emboli, renal emboli 2,901 2,736 102 * 47 0.8 0.1 0.2 0.2 Cystic/heriditary/congenital diseases 16,890 13,93 2,332 118 672 3.9 1. 2.0 3.1 Polycystic kidneys, adult type (dominant) 11,948 9,76 1,96 0 468 2.8 1.1 0.8 2.2 Polycystic, infantile (recessive) 2 189 46 * * 0.1... Medullary cystic disease, including nephronophthisis 244 207 1 * 14 0.1. 0.1 0.1 Tuberous sclerosis 196 14 3. *.... Hereditary nephritis, Alport's syndrome 777 66 70 * 31 0.2. 0.1 0.1 Cystinosis 93 83 * * *.... Primary oxalosis 2 38 * * *.... Fabry's disease 103 89 11. *.... Congenital nephrotic syndrome 318 216 78 * 17 0.1 0.1. 0.1 Drash syndrome, mesangial sclerosis 62 47 *. *.... Congenital obstruction of ureterpelvic junction 170 126 31 * *.. 0.1. Congenital obstruction of uretrovesical junction 78 9 12 * *.... Other congenital obstructive uropathy 1,062 776 198 19 46 0.2 0.1 0.3 0.2 Renal hypoplasia, dysplasia, oligonephronia 994 748 14 17 1 0.2 0.1 0.3 0.2 Prune belly syndrome 120 89 24 * *.... Other (congenital malformation syndromes) 418 31 48 * 11 0.1. 0.1 0.1 pg 442

Table A.7 (continued) Incidence of reported ESRD, by primary diagnosis, 2003 2007 2003-2007 combined by detailed primary diagnosis Total Counts Percent COLUMN PERCENT patients White Af Am N Am Asian White Af Am N Am Asian Neoplasms/tumors 12,870 10,260 2,222 73 24 2.9 1. 1.2 1.2 Renal tumor (malignant) 2,011 1,671 291 1 26 0. 0.2 0.3 0.1 Urinary tract tumor (malignant) 698 81 96 * 14 0.2 0.1 0.1 0.1 Renal tumor (benign) 83 67 13. *.... Urinary tract tumor (benign) 46 *...... Renal tumor (unspecified) 230 184 39 * * 0.1... Urinary tract tumor (unspecified) 134 10 21 * *.... Lymphoma of kidneys 192 19 30 * *.... Multiple myeloma,821 4,422 1,249 28 100 1.3 0.8 0. 0. Other immuno prolif. neoplasms (inc. light chain neph.) 686 69 98 * * 0.2 0.1 0.1. Amyloidosis 1,33 1,081 206 * 34 0.3 0.1 0.1 0.2 Complications of transplanted organ, unspecified 40 33 *. *.... Complications of transplanted kidney 79 9 * * 13... 0.1 Complications of transplanted liver 860 740 84 * 23 0.2 0.1 0.1 0.1 Complications of transplanted heart 409 340 7 * * 0.1... Complications of transplanted lung 108 100 *. *.... Complications of transplanted bone marrow 9 0 *. *.... Complications of transplanted pancreas 46 33 * * *.... Complications of transplanted intestine * * *...... Complications of other specified transplanted organ 21 18 *. *.... Miscellaneous conditions 27,47 18,846 7,721 149 9.4.1 2. 2.6 Sickle cell disease/anemia 499 * 48. *. 0.3.. Sickle cell trait and other sickle cell (HbS/Hb other) 29. 29...... Post-partum renal failure 104 61 3. *.... AIDS nephropathy 4,208 4 3,691 * * 0.1 2.4 0.2. Traumatic or surgical loss of kidney(s) 87 479 89 * 11 0.1 0.1 0.1 0.1 Hepatorenal syndrome 2,18 1,78 268 34 80 0. 0.2 0.6 0.4 Tubular necrosis (no recovery) 13,047 10,613 2,046 69 240 3.0 1.4 1.2 1.1 Other renal disorders 6,82,470 1,078 33 213 1.6 0.7 0.6 1.0 Etiology uncertain 22,293 16,109 4,729 169 1,030 4.6 3.1 2.8 4.8 Missing 4,67 2,087 984 44 238 0.6 0.6 0.7 1.1 Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD Vol 3 esrd pg 443

Table A.8 Incident counts of reported ESRD patients, by diabetic status & state/territory ALL 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 Alabama 332 48 939 1,338 1,71 1,829 1,81 1,863 1,914 1,93 2,101 1,989 Alaska * 14 32 228 84 9 76 102 11 91 121 140 Arizona 267 472 786 1,210 1,720 1,80 1,809 1,908 1,98 1,933 2,06 2,03 Arkansas 140 27 423 717 86 894 93 923 1,00 978 1,040 1,063 California 1,866 3,327,667 7,878 10,774 11,23 11,761 11,989 12,209 12,226 12,68 13,133 Colorado 183 267 43 3 793 790 843 824 943 92 922 910 Connecticut 22 484 621 803 1,022 982 987 972 989 1,014 996 996 Delaware 4 94 143 232 301 276 299 38 33 362 389 34 District of Columbia 117 20 273 386 43 422 433 429 429 436 423 379 Florida 1,139 1,818 3,116 4,278,848 6,084 6,216 6,374 6,81 6,71 6,92 6,882 Georgia 484 816 1,01 2,270 3,22 3,301 3,33 3,438 3,322 3,616 3,829 3,83 Hawaii 8 176 278 386 23 482 49 492 66 74 627 86 Idaho 2 8 144 184 28 294 262 272 279 302 272 31 Illinois 830 1,22 2,300 3,467 4,34 4,44 4,819 4,680 4,690 4,878,009,084 Indiana 33 600 1,002 1,33 1,927 1,962 2,004 2,032 2,034 2,174 2,301 2,28 Iowa 17 267 440 14 723 76 763 771 776 839 827 70 Kansas 131 221 404 487 688 671 709 730 71 794 794 778 Kentucky 231 372 664 866 1,229 1,323 1,262 1,334 1,442 1,29 1,491 1,04 Louisiana 322 9 1,103 1,6 1,981 2,139 2,227 2,320 2,247 2,184 2,17 2,20 Maine 39 94 146 223 307 312 310 326 333 349 347 271 Maryland 318 87 1,066 1,690 2,221 2,243 2,36 2,373 2,411 2,19 2,9 2,409 Massachusetts 397 82 931 1,342 1,701 1,671 1,667 1,783 1,783 1,762 1,812 1,77 Michigan 766 1,126 1,800 2,48 3,34 3,6 3,61 3,89 3,778 4,009 3,987 3,90 Minnesota 261 43 691 821 1,100 1,247 1,224 1,179 1,322 1,29 1,07 1,36 Mississippi 212 34 649 897 1,14 1,20 1,326 1,348 1,321 1,13 1,433 1,496 Missouri 331 613 1,012 1,419 1,888 1,948 1,849 1,996 1,988 1,999 2,0 2,131 Montana 30 66 12 160 169 216 172 198 189 193 198 199 Nebraska 88 144 219 326 493 3 483 490 26 23 4 24 Nevada 90 126 210 34 63 627 627 714 729 744 82 838 New Hampshire 3 88 121 179 278 2 267 29 322 30 288 277 New Jersey 81 1,29 1,831 2,6 3,128 3,284 3,301 3,370 3,328 3,48 3,67 3,649 New Mexico 121 17 289 42 60 67 4 614 631 93 641 629 New York 1,49 2,376 3,839 4,98 6,496 6,619 6,670 6,819 7,046 7,06 7,282 7,330 North Carolina 06 901 1,42 2,120 3,083 3,180 3,172 3,272 3,317 3,14 3,47 3,30 North Dakota 26 6 102 116 18 196 179 168 179 202 214 210 Ohio 708 1,249 2,236 2,919 4,246 4,271 4,320 4,09 4,472 4,64 4,713 4,829 Oklahoma 202 301 97 774 1,084 1,147 1,131 1,263 1,230 1,213 1,249 1,287 Oregon 129 21 409 68 749 801 81 90 89 869 901 944 Pennsylvania 941 1,709 2,687 3,00 4,66 4,40 4,770 4,14 4,801 4,804,14,042 Rhode Island 76 122 182 228 329 320 314 331 323 333 312 318 South Carolina 269 49 94 1,230 1,628 1,699 1,649 1,847 2,000 1,874 1,891 1,913 South Dakota 42 76 91 182 244 230 29 2 241 21 22 233 Tennessee 336 63 1,078 1,470 1,929 1,900 1,992 2,063 2,124 2,278 2,31 2,421 Texas 1,073 1,943 3,94 4,928 6,983 7,247 7,46 7,902 8,00 8,349 8,871 8,832 Utah 92 121 193 26 344 416 371 369 374 434 439 434 Vermont 37 4 68 102 127 109 129 143 127 16 149 12 Virginia 06 764 1,227 1,864 2,283 2,09 2,674 2,674 2,770 2,732 2,970 2,837 Washington 243 40 689 94 1,337 1,311 1,434 1,46 1,446 1,46 1,33 1,78 West Virginia 118 197 302 483 704 73 697 709 772 744 79 763 Wisconsin 308 469 780 1,039 1,413 1,498 1,88 1,630 1,766 1,740 1,813 1,674 Wyoming 14 44 32 63 86 83 79 88 8 97 76 91 American Samoa * * * * 18 1 1 19 24 * 19 16 Guam * * 29 0 69 82 96 89 80 88 93 111 Puerto Rico 239 391 611 837 1,103 1,174 1,213 1,289 1,294 1,237 1,332 1,30 Saipan. * * 14 18 * 16 19 20 19 19 30 Virgin Islands * 13 20 31 31 38 44 42 48 4 72 2 Foreign * 20 41 33 39 27 34 29 19 22 29 13 Unknown 110 143 282 38 34 22 2 187 28 304 311 319 pg 444 All 17,978 30,33 0,89 70,393 94,27 97,792 99,970 102,677 104,962 107,230 111,008 111,000 on our website & cd Incident counts of reported ESRD patients, by diabetic status & state: U.S. only, with unknowns dropped (A.8.1).

Table A.8 (continued) Incident counts of reported ESRD patients, by diabetic status & state/territory DIABETIC 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 Alabama 26 120 297 19 772 837 780 823 80 82 917 899 Alaska * * 11 84 3 49 37 44 7 37 1 9 Arizona 64 181 348 629 912 90 98 99 1,011 962 1,03 1,02 Arkansas * 74 130 277 362 381 400 416 424 407 443 427 California 213 1,041 2,090 3,373,174,233,490,47,738,661,803 6,061 Colorado 39 9 188 260 390 381 407 400 434 43 438 441 Connecticut 29 149 212 31 41 39 416 447 40 408 439 409 Delaware * 2 2 77 132 116 121 16 129 16 149 146 District of Columbia * 70 87 13 162 16 10 163 149 172 1 132 Florida 126 427 93 1,21 2,368 2,33 2,491 2,633 2,702 2,771 2,897 2,873 Georgia 3 222 03 912 1,378 1,399 1,474 1,466 1,432 1,490 1,667 1,9 Hawaii 23 8 14 226 323 304 296 292 341 361 40 368 Idaho * 17 1 73 117 111 116 103 126 139 111 17 Illinois 142 449 770 1,317 1,774 1,848 1,922 1,887 1,876 2,00 1,971 1,97 Indiana 43 1 361 88 816 821 84 904 90 929 938 99 Iowa 27 8 138 224 296 314 303 306 319 34 396 313 Kansas 24 64 13 183 331 304 317 308 319 316 340 308 Kentucky 38 9 23 362 6 618 96 628 677 662 666 690 Louisiana 31 130 36 608 86 962 966 1,002 979 897 973 960 Maine * 24 42 78 133 132 130 136 147 148 142 119 Maryland 37 181 38 639 841 927 993 879 88 993 94 892 Massachusetts 62 122 301 19 649 72 646 68 67 679 703 686 Michigan 17 336 707 1,041 1,04 1,641 1,82 1,63 1,63 1,668 1,673 1,629 Minnesota 72 14 264 331 41 49 463 42 490 490 8 498 Mississippi 2 80 229 377 499 47 87 81 19 92 8 63 Missouri 19 181 329 8 840 839 809 876 86 846 867 917 Montana * 22 9 8 78 119 84 103 93 93 83 79 Nebraska 16 38 79 163 212 240 206 208 247 222 24 233 Nevada 19 27 81 164 264 303 312 32 337 337 379 361 New Hampshire * 20 41 67 111 91 98 114 132 107 114 103 New Jersey 12 340 68 1,030 1,327 1,343 1,37 1,364 1,373 1,46 1,01 1,8 New Mexico 26 61 129 21 3 38 310 340 384 368 368 373 New York 203 624 1,246 1,901 2,699 2,837 2,817 2,83 2,938 2,891 3,034 3,09 North Carolina 69 242 10 86 1,362 1,387 1,3 1,446 1,22 1,96 1, 1,48 North Dakota * 18 4 1 60 84 89 72 79 84 93 90 Ohio 144 398 81 1,287 2,006 2,042 1,988 2,067 2,112 2,20 2,12 2,134 Oklahoma 2 100 26 381 0 63 600 88 621 98 638 Oregon 20 69 142 230 307 326 302 340 36 337 372 366 Pennsylvania 17 42 918 1,443 1,960 2,011 2,00 1,924 2,03 2,004 2,201 2,149 Rhode Island * 24 9 84 104 123 114 111 119 113 109 112 South Carolina 41 167 309 487 736 781 746 86 920 80 864 836 South Dakota * 32 32 93 109 104 119 122 107 111 107 100 Tennessee 34 133 348 88 837 817 823 940 92 9 1,00 1,03 Texas 17 632 1,3 2,41 3,702 3,792 4,014 4,181 4,289 4,412 4,866 4,668 Utah 33 90 146 169 207 164 188 191 220 22 218 Vermont * 16 22 1 49 46 4 3 47 63 69 46 Virginia 60 172 376 70 1,001 1,147 1,172 1,128 1,200 1,203 1,268 1,233 Washington 43 139 238 377 71 3 72 610 608 67 67 660 West Virginia 19 3 112 21 378 389 36 362 373 369 410 38 Wisconsin 76 14 306 431 62 90 601 636 719 73 72 642 Wyoming * 21 12 38 4 33 36 4 3 46 3 37 Section A 2009 USRDS Annual Data Report 4 Incidence of reported ESRD American Samoa. * * * 17 14 11 1 19 * 13 12 Guam * * 13 34 39 6 61 63 69 76 Puerto Rico 39 138 297 447 691 72 761 832 807 796 847 868 Saipan.. * * 14 * 12 1 16 1 17 21 Virgin Islands. * * 19 19 20 18 23 24 28 47 30 Foreign. * * * * * 13 1 * * 13 * Unknown * 24 94 * * *. * * * * * All 2,689 8,703 18,10 29,326 42,427 44,140 44,447 4,644 46,71 47,389 49,340 48,871 Vol 3 esrd pg 44

Table A.8 (continued) Incident counts of reported ESRD patients, by diabetic status & state/territory NON-DIABETIC 1980 198 1990 199 2000 2001 2002 2003 2004 200 2006 2007 Alabama 306 428 642 819 979 992 1,03 1,040 1,064 1,110 1,184 1,090 Alaska * 11 21 144 49 46 39 8 8 4 70 81 Arizona 203 291 438 81 808 8 81 913 974 971 1,003 983 Arkansas 131 201 293 440 03 13 3 07 81 71 97 636 California 1,63 2,286 3,77 4,0,600 6,002 6,271 6,442 6,471 6,6 6,882 7,072 Colorado 144 172 247 293 403 409 436 424 09 490 484 469 Connecticut 196 33 409 488 71 87 71 2 84 606 7 87 Delaware 38 69 91 1 169 160 178 202 206 197 240 208 District of Columbia 107 13 186 21 291 27 283 266 280 264 268 247 Florida 1,013 1,391 2,181 2,77 3,480 3,1 3,72 3,741 3,879 3,800 4,0 4,009 Georgia 431 94 998 1,38 1,847 1,902 1,861 1,972 1,890 2,126 2,162 2,240 Hawaii 62 118 133 160 200 178 199 200 22 213 222 218 Idaho 42 68 93 111 141 183 146 169 13 163 161 194 Illinois 688 1,073 1,30 2,10 2,71 2,696 2,897 2,793 2,814 2,873 3,038 3,109 Indiana 292 44 641 76 1,111 1,141 1,10 1,128 1,129 1,24 1,363 1,299 Iowa 148 182 302 290 427 442 460 46 47 48 431 437 Kansas 107 17 269 304 37 367 392 422 396 478 44 470 Kentucky 193 277 429 04 673 70 666 706 76 867 82 814 Louisiana 291 46 738 97 1,12 1,177 1,261 1,318 1,268 1,287 1,202 1,290 Maine 32 70 104 14 174 180 180 190 186 201 20 12 Maryland 281 406 681 1,01 1,380 1,316 1,363 1,494 1,3 1,26 1,60 1,17 Massachusetts 33 460 630 823 1,02 946 1,021 1,098 1,126 1,083 1,109 1,071 Michigan 91 790 1,093 1,444 1,80 1,91 2,033 2,026 2,12 2,341 2,314 2,276 Minnesota 189 290 427 490 68 788 761 74 832 80 949 88 Mississippi 187 274 420 20 6 703 739 767 802 921 848 933 Missouri 312 432 683 834 1,048 1,109 1,040 1,120 1,132 1,13 1,188 1,214 Montana 2 44 66 7 91 97 88 9 96 100 11 120 Nebraska 72 106 140 163 281 29 277 282 279 301 309 291 Nevada 71 99 129 190 299 324 31 362 392 407 446 477 New Hampshire 47 68 80 112 167 164 169 181 190 198 174 174 New Jersey 726 919 1,173 1,3 1,801 1,941 1,926 2,006 1,9 2,020 2,066 2,064 New Mexico 9 114 160 174 20 209 23 274 247 22 273 26 New York 1,26 1,72 2,93 3,084 3,797 3,782 3,83 3,966 4,108 4,16 4,248 4,23 North Carolina 437 69 942 1,2 1,721 1,793 1,817 1,826 1,79 1,918 1,902 1,982 North Dakota 19 38 7 6 98 112 90 96 100 118 121 120 Ohio 64 81 1,421 1,632 2,240 2,229 2,332 2,442 2,360 2,404 2,61 2,69 Oklahoma 177 201 341 393 34 84 76 663 642 92 61 649 Oregon 109 182 267 338 442 47 49 6 03 32 29 78 Pennsylvania 766 1,27 1,769 2,07 2,606 2,29 2,76 2,90 2,766 2,800 2,944 2,893 Rhode Island 67 98 123 144 22 197 200 220 204 220 203 206 South Carolina 228 382 636 743 892 918 903 991 1,080 1,069 1,027 1,077 South Dakota 32 44 9 89 13 126 140 133 134 140 118 133 Tennessee 302 430 730 882 1,092 1,083 1,169 1,123 1,199 1,323 1,310 1,386 Texas 916 1,311 2,09 2,13 3,281 3,4 3,442 3,721 3,761 3,937 4,00 4,164 Utah 9 66 103 119 17 209 207 181 183 214 214 216 Vermont 31 29 46 1 78 63 7 90 80 93 80 79 Virginia 446 92 81 1,19 1,282 1,362 1,02 1,46 1,70 1,29 1,702 1,604 Washington 200 266 41 68 766 78 862 846 838 889 876 918 West Virginia 99 144 190 268 326 364 341 347 399 37 38 378 Wisconsin 232 324 474 608 81 908 987 994 1,047 1,00 1,088 1,032 Wyoming 11 23 20 2 41 0 43 43 0 1 41 4 American Samoa * * * * * * * * * * * * Guam * * 16 16 30 26 3 26 2 33 24 3 Puerto Rico 200 23 314 390 412 422 42 47 487 441 48 482 Saipan. *. * *. * * * * * * Virgin Islands * 12 18 12 12 18 26 19 24 26 2 22 Foreign * 18 34 26 33 17 21 14 11 13 16 * Unknown 10 119 188 36 33 21 2 186 24 301 306 31 All 1,289 21,830 32,709 41,067 2,100 3,62,23 7,033 8,247 9,841 61,668 62,129 pg 446